{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:43:59Z","timestamp":1791359039807,"version":"4.3.1"},"reference-count":174,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.mrfmmm.2024.111896","type":"journal-article","created":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T11:12:33Z","timestamp":1735211553000},"page":"111896","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Genomic and molecular landscape of gallbladder cancer elucidating pathogenic mechanisms novel therapeutic targets and clinical implications"],"prefix":"10.1016","volume":"830","author":[{"given":"Manishankar","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhinav","family":"Srivastav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2586-9397","authenticated-orcid":false,"given":"Dhruv","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mrfmmm.2024.111896_bib1","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/ijc.27777","article-title":"Risk factors for gallbladder cancer: a case-control study","volume":"132","author":"Jain","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41572-022-00398-y","article-title":"Gallbladder cancer","volume":"8","author":"Roa","year":"2022","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib3","first-page":"185","article-title":"Biphasic large cell neuroendocrine carcinoma--pure mucinous carcinoma of the gallbladder (MANEC): a unique combination","volume":"104","author":"Russo","year":"2012","journal-title":"Pathologica"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib4","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1158\/0008-5472.CAN-19-0459","article-title":"Anthropometric risk factors for cancers of the biliary tract in the biliary tract cancers pooling project","volume":"79","author":"Jackson","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib5","doi-asserted-by":"crossref","DOI":"10.21037\/cco.2019.08.03","article-title":"Epidemiology of gallbladder cancer in India","volume":"8","author":"Dutta","year":"2019","journal-title":"Chin. Clin. Oncol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib6","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.humpath.2013.11.001","article-title":"Molecular characterization of gallbladder cancer using somatic mutation profiling","volume":"45","author":"Javle","year":"2014","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib7","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/archsurg.2009.46","article-title":"Trends in presentation and survival for gallbladder cancer during a period of more than 4 decades: a single-institution experience","volume":"144","author":"Konstantinidis","year":"2009","journal-title":"Arch. Surg."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib8","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/ijc.21683","article-title":"Gallbladder cancer worldwide: geographical distribution and risk factors","volume":"118","author":"Randi","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13045-022-01253-z","article-title":"Immune cell atlas of cholangiocarcinomas reveals distinct tumor microenvironments and associated prognoses","volume":"15","author":"Xia","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib10","first-page":"1","article-title":"Impact of preoperative biliary drainage on postoperative complications and prognosis after pancreaticoduodenectomy: a single-center retrospective cohort study","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib11","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/jnci\/89.15.1132","article-title":"Epidemiologic aspects of gallbladder cancer: a case- control study of the SEARCH Program of the International Agency for Research on Cancer","volume":"89","author":"Zatonski","year":"1997","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib12","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4103\/0019-509X.197723","article-title":"Place of birth and risk of gallbladder cancer in India","volume":"53","author":"Mhatre","year":"2016","journal-title":"Indian J. Cancer"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib13","first-page":"99","article-title":"Gallbladder cancer: epidemiology and outcome","volume":"6","author":"Hundal","year":"2014","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib14","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/1477-7819-9-164","article-title":"Risk factors of gallbladder cancer in Karachi-a case- control study","volume":"9","author":"Alvi","year":"2011","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib15","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ijsu.2011.07.001","article-title":"Gallbladder intestinal metaplasia in Pakistani patients with gallstones","volume":"9","author":"Khan","year":"2011","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib16","first-page":"209","article-title":"Gallbladder cancer: an \u201cIndian\u201d disease","volume":"16","author":"Kapoor","year":"2003","journal-title":"Natl. Med J. India"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.153806","article-title":"Genomic profiling of gallbladder carcinoma: targetable mutations and pathways involved","volume":"232","author":"Mishra","year":"2022","journal-title":"Pathol. Res Pract."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib18","first-page":"27","author":"Hollosi","year":"2013","journal-title":"Validation of the Method for Determination of Pesticide Residues by Gas Chromatography \u2013 Triple-Stage Quadrupole Mass Spectrometry."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib19","article-title":"PI3K\/Akt\/mTOr pathway and its role in cancer therapeutics: are we making headway?","volume":"12","author":"Peng","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1634\/theoncologist.2011-0386","article-title":"Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad- based tumor genotyping","volume":"17","author":"Borger","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib21","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/cam4.2794","article-title":"Landscape of distant metastasis mode and current chemotherapy efficacy of the advanced biliary tract cancer in the United States, 2010-2016","volume":"9","author":"Wang","year":"2020","journal-title":"Cancer Med."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib22","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1080\/00365521.2019.1619827","article-title":"Prognosis and prognostic factors in patients with advanced biliary tract cancer depending on its anatomical location","volume":"54","author":"Song","year":"2019","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/cam4.2679","article-title":"Treatment of advanced gallbladder cancer: a SEER-based study","volume":"9","author":"Mao","year":"2020","journal-title":"Cancer Med."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib24","doi-asserted-by":"crossref","unstructured":"M.A. Schmidt, L. Marcano-Bonilla, L.R. Roberts, Gallbladder cancer: epidemiology and genetic risk associations, Chinese Clinical Oncology; Vol 8, No 4 (August 27, 2019): Chinese Clinical Oncology (Gallbladder Cancer) (2019).","DOI":"10.21037\/cco.2019.08.13"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib25","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/hep.30861","article-title":"A Metallomic approach to assess associations of serum metal levels with gallstones and gallbladder cancer","volume":"71","author":"Lee","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib26","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1158\/1055-9965.EPI-22-0926","article-title":"Chronic exposure to drinking water arsenic and gallbladder cancer risk: preliminary evidence from endemic regions of India","volume":"32","author":"Shridhar","year":"2023","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib27","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/jso.20528","article-title":"Gallstones and gallbladder cancer-volume and weight of gallstones are associated with gallbladder cancer: a case- control study","volume":"93","author":"Roa","year":"2006","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib28","first-page":"1","article-title":"Arsenic causing gallbladder cancer disease in Bihar","volume":"13","author":"Kumar","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib29","doi-asserted-by":"crossref","first-page":"699","DOI":"10.4103\/ijmr.IJMR_201_19","article-title":"Risk factors for gallbladder cancer development in northern India: a gallstones-matched, case-control study","volume":"154","author":"Mishra","year":"2021","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib30","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1136\/bmj.317.7168.1288","article-title":"Biliary heavy metal concentrations in carcinoma of the gall bladder: case-control study","volume":"317","author":"Shukla","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib31","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1007\/s00268-013-2164-9","article-title":"Heavy and trace metals in carcinoma of the gallbladder","volume":"37","author":"Basu","year":"2013","journal-title":"World J. Surg."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib32","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1470-2045(09)70134-2","article-title":"A review of human carcinogens\u2014part C: metals, arsenic, dusts, and fibres","volume":"10","author":"Straif","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib33","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/oxfordjournals.aje.a010243","article-title":"Respiratory cancer in a cohort of copper smelter workers: results from more than 50 years of follow-up","volume":"151","author":"Lubin","year":"2000","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ebiom.2014.10.005","article-title":"Rapid reduction in breast cancer mortality with inorganic arsenic in drinking water","volume":"1","author":"Smith","year":"2014","journal-title":"EBioMedicine"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib35","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1309\/LMYKGU05BEPE7IAW","article-title":"Testing for toxic elements: a focus on arsenic, cadmium, lead, and mercury","volume":"42","author":"Keil","year":"2011","journal-title":"Lab Med."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib36","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/35017574","article-title":"Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation","volume":"406","author":"Hoeflich","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib37","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/2156587211407638","article-title":"Growing evidence for human health benefits of boron","volume":"16","author":"Nielsen","year":"2011","journal-title":"J. Evid. Based Complement. Alter. Med."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib38","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jtemb.2018.08.009","article-title":"Profile of three boron-containing compounds on the body weight, metabolism and inflammatory markers of diabetic rats","volume":"50","author":"L\u00f3pez-Cabrera","year":"2018","journal-title":"J. Trace Elem. Med. Biol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib39","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1158\/1055-9965.EPI-16-0796","article-title":"Body size indicators and risk of gallbladder cancer: pooled analysis of individual-level data from 19 prospective cohort studies","volume":"26","author":"Campbell","year":"2017","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib40","first-page":"987","article-title":"Height and body mass index in relation to colorectal and gallbladder cancer in two million Norwegian men and women","volume":"16","author":"Engeland","year":"2005","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jtemb.2005.10.003","article-title":"Serum molybdenum concentration in healthy Japanese adults determined by inductively coupled plasma-mass spectrometry","volume":"20","author":"Yoshida","year":"2006","journal-title":"J. Trace Elem. Med. Biol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib42","first-page":"1","article-title":"Role of ring oxidation in the metabolic activation of 1-nitropyrene","author":"Beland","year":"1991","journal-title":"Res Rep. Health Eff. Inst."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/nu13020287","article-title":"Dietary habits, selenium, copper, zinc and total antioxidant status in serum in relation to cognitive functions of patients with Alzheimer\u2019s disease","volume":"13","author":"Socha","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib44","first-page":"139","article-title":"Evaluation of blood concentrations of copper and molybdenum in type 2 diabetic patients","volume":"6","author":"Alian","year":"2017","journal-title":"J. Biol. Today\u2019s World"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib45","article-title":"Magnesium: does a mineral prevent gallstones?","volume":"103","author":"Ko","year":"2008","journal-title":"Off. J. Am. Coll. Gastroenterol. ACG"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib46","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1572-0241.2007.01696.x","article-title":"Long-term effect of magnesium consumption on the risk of symptomatic gallstone disease among men","volume":"103","author":"Tsai","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib47","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/bjc.2011.363","article-title":"Metabolic syndrome and insulin resistance in relation to biliary tract cancer and stone risks: a population-based study in Shanghai, China","volume":"105","author":"Shebl","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040162","article-title":"Significant role of estrogen and progesterone receptor sequence variants in gallbladder cancer predisposition: a multi- analytical strategy","volume":"7","author":"Srivastava","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib49","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mrrev.2011.06.002","article-title":"Candidate gene studies in gallbladder cancer: a systematic review and meta-analysis","volume":"728","author":"Srivastava","year":"2011","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib50","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.3748\/wjg.v23.i22.3978","article-title":"Gallbladder cancer epidemiology, pathogenesis and molecular genetics: recent update","volume":"23","author":"Sharma","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib51","doi-asserted-by":"crossref","first-page":"R212","DOI":"10.1530\/EC-18-0099","article-title":"The growth hormone-insulin-like growth factor-I axis in the diagnosis and treatment of growth disorders","volume":"7","author":"Blum","year":"2018","journal-title":"Endocr. Connect"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib52","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41392-020-00324-2","article-title":"Overview of current targeted therapy in gallbladder cancer","volume":"5","author":"Song","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib53","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/mc.20641","article-title":"Caspase-8 polymorphisms and risk of gallbladder cancer in a northern Indian population","volume":"49","author":"Srivastava","year":"2010","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib54","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3748\/wjg.14.70","article-title":"Genetic changes of p53, K-ras, and microsatellite instability in gallbladder carcinoma in high- incidence areas of Japan and Hungary","volume":"14","author":"Nagahashi","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib55","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cytogfr.2014.03.004","article-title":"Regulation and dysregulation of tumor necrosis factor receptor-1","volume":"25","author":"Puim\u00e8ge","year":"2014","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib56","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1152\/physrev.00045.2017","article-title":"The TNF family of ligands and receptors: communication modules in the immune system and beyond","volume":"99","author":"Dostert","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib57","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0002-9440(10)64219-8","article-title":"Frequent Fas gene mutations in testicular germ cell tumors","volume":"161","author":"Takayama","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib58","doi-asserted-by":"crossref","first-page":"22502","DOI":"10.18632\/aging.203561","article-title":"Melatonin inhibits proliferation, migration, and invasion by inducing ROS-mediated apoptosis via suppression of the PI3K\/Akt\/mTOR signaling pathway in gallbladder cancer cells","volume":"13","author":"Chen","year":"2021","journal-title":"Aging"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib59","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jhep.2020.11.033","article-title":"Integrative molecular characterisation of gallbladder cancer reveals micro-environment-associated subtypes","volume":"74","author":"Nepal","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib60","first-page":"370","article-title":"Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells","volume":"1826","author":"Chen","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib61","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00432-018-2817-z","article-title":"TP53 mutations as potential prognostic markers for specific cancers: analysis of data from The Cancer Genome Atlas and the International Agency for Research on Cancer TP53 Database","volume":"145","author":"Li","year":"2019","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib62","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s12029-018-00188-4","article-title":"Histopathological examination of gallbladder specimens in Kumaon region of Uttarakhand","volume":"51","author":"Shukla","year":"2020","journal-title":"J. Gastrointest. Cancer"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib63","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13046-016-0346-7","article-title":"Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer","volume":"35","author":"Cao","year":"2016","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib64","first-page":"245","article-title":"The inflammatory inception of gallbladder cancer","volume":"1865","author":"Espinoza","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib65","doi-asserted-by":"crossref","first-page":"221","DOI":"10.5114\/pjp.2012.32768","article-title":"Impact of COX-2, IL-1\u03b2, TNF-\u03b1, IL-4 and IL-10 on the process of carcinogenesis in the large bowel","volume":"63","author":"Marsza\u0142ek","year":"2012","journal-title":"Pol. J. Pathol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib66","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/CEJ.0000000000000521","article-title":"Exploring the potential carcinogenic role of arsenic in gallbladder cancer","author":"Ganesan","year":"2020","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib67","doi-asserted-by":"crossref","first-page":"22087","DOI":"10.1038\/s41598-020-77939-6","article-title":"Genomic profiling reveals high frequency of DNA repair genetic aberrations in gallbladder cancer","volume":"10","author":"Abdel-Wahab","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13215257","article-title":"Gallbladder cancer: current insights in genetic alterations and their possible therapeutic implications","volume":"13","author":"Kuipers","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib69","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.mrrev.2018.08.003","article-title":"Genetic landscape of gallbladder cancer: global overview","volume":"778","author":"Mehrotra","year":"2018","journal-title":"Mutat. Res Rev. Mutat. Res."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib70","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/ng.3030","article-title":"Whole- exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway","volume":"46","author":"Li","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib71","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1038\/s41467-020-15912-7","article-title":"Mutational signatures are jointly shaped by DNA damage and repair","volume":"11","author":"Volkova","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib72","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/em.22087","article-title":"Mechanisms of DNA damage, repair, and mutagenesis","volume":"58","author":"Chatterjee","year":"2017","journal-title":"Environ. Mol. Mutagen"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib73","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41392-021-00648-7","article-title":"DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib74","doi-asserted-by":"crossref","first-page":"7073","DOI":"10.1038\/s41598-020-63759-1","article-title":"Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes","volume":"10","author":"De Talhouet","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib75","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/s41419-022-05408-1","article-title":"Mutant p53 in cancer: from molecular mechanism to therapeutic modulation","volume":"13","author":"Chen","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12041050","article-title":"DNA damage\/repair management in cancers","volume":"12","author":"Alhmoud","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib77","unstructured":"B. Miles, P. Tadi, Genetics, Somatic Mutation., in: Treasure Island (FL), 2023."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib78","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41392-020-0196-9","article-title":"Regulating tumor suppressor genes: post-translational modifications","volume":"5","author":"Chen","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib79","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1440-1746.2004.03355.x","article-title":"Mutational spectrum of K-ras oncogene among Indian patients with gallbladder cancer","volume":"19","author":"Singh","year":"2004","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib80","first-page":"333","author":"Itoi","year":"1996","journal-title":"Carcinoma and Adenoma of the Gall-bladder Suggest Two Genetic Pathways in Gall-bladder Carcinogenesis"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib81","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s12029-019-00283-0","article-title":"Genetic changes of P 53 and Kras in gallbladder carcinoma in Kumaon region of Uttarakhand","volume":"51","author":"Shukla","year":"2020","journal-title":"J. Gastrointest. Cancer"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib82","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.7150\/thno.56539","article-title":"Mutational spectrum and precision oncology for biliary tract carcinoma","volume":"11","author":"Lin","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib83","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.suronc.2010.09.003","article-title":"Genetic aberrations in gallbladder cancer","volume":"21","author":"Maurya","year":"2012","journal-title":"Surg. Oncol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib84","first-page":"251","article-title":"[P53 gene mutation in gallbladder cancer]","volume":"128","author":"Roa","year":"2000","journal-title":"Rev. Med. Chil."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib85","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/ng0593-42","article-title":"Gain of function mutations in p53","volume":"4","author":"Dittmer","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib86","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/ng.3030","article-title":"Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway","volume":"46","author":"Li","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib87","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.suronc.2010.09.003","article-title":"Genetic abberations in gallbladder cancer","volume":"21","author":"Maurya","year":"2012","journal-title":"Surg. Oncol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib88","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.annonc.2021.03.046","article-title":"32P PIK3CA exon 9 and 20 mutations in early luminal breast cancer: case series and review of the literature","volume":"32","author":"Betancor Fern\u00e1ndez","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib89","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.70885","article-title":"A MET-PTPRK kinase-phosphatase rheostat controls ZNRF3 and Wnt signaling","volume":"10","author":"Kim","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib90","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12943-018-0796-y","article-title":"Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities","volume":"17","author":"Zhang","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib91","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12943-022-01503-1","article-title":"Molecular mechanism(s) of regulation(s) of c- MET\/HGF signaling in head and neck cancer","volume":"21","author":"Raj","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib92","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.7150\/jca.17898","article-title":"The clinical impact of c-MET over-expression in advanced biliary tract cancer (BTC","volume":"8","author":"Heo","year":"2017","journal-title":"J. Cancer"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib93","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jmoldx.2022.04.005","article-title":"MET Exon 14 skipping mutations: essential considerations for current management of non\u2013small-cell lung cancer","volume":"24","author":"Davies","year":"2022","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib94","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41568-018-0002-y","article-title":"Known and novel roles of the MET oncogene in cancer: a coherent approach to targeted therapy","volume":"18","author":"Comoglio","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib95","doi-asserted-by":"crossref","first-page":"481","DOI":"10.4143\/crt.2019.370","article-title":"Prevalence and clinicopathological significance of MET overexpression and gene amplification in patients with gallbladder carcinoma","volume":"52","author":"Kim","year":"2020","journal-title":"Cancer Res Treat."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib96","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1101\/gad.1067003","article-title":"Genomic targets of the human c-Myc protein","volume":"17","author":"Fernandez","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib97","first-page":"68","article-title":"[The roles of VEGF and C-myc in occurrence, development and metastasis of gallbladder carcinoma]","volume":"20","author":"Liu","year":"2003","journal-title":"Sheng Wu Yi Xue Gong. Cheng Xue Za Zhi"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib98","first-page":"19","article-title":"Gene amplification of Myc and its coamplification with ERBB2 and EGFR in gallbladder adenocarcinoma","volume":"29","author":"Ooi","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib99","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004795","article-title":"Sophisticated framework between cell cycle arrest and apoptosis induction based on p53 dynamics","volume":"4","author":"Hamada","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060576","article-title":"Prognostic and predictive significance of myc and kras alterations in breast cancer from women treated with neoadjuvant chemotherapy","volume":"8","author":"Pereira","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib101","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064420","article-title":"MYC deregulation in gastric cancer and its clinicopathological implications","volume":"8","author":"de Souza","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib102","doi-asserted-by":"crossref","first-page":"5962","DOI":"10.3748\/wjg.14.5962","article-title":"MYC and gastric adenocarcinoma carcinogenesis","volume":"14","author":"Calcagno","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib103","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/nrc2231","article-title":"Reflecting on 25 years with MYC","volume":"8","author":"Meyer","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib104","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nature08822","article-title":"The landscape of somatic copy- number alteration across human cancers","volume":"463","author":"Beroukhim","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib105","doi-asserted-by":"crossref","first-page":"471","DOI":"10.5604\/17322693.1201719","article-title":"[BRAF mutation in progression and therapy of melanoma, papillary thyroid carcinoma and colorectal adenocarcinoma]","volume":"70","author":"Zale\u015bna","year":"2016","journal-title":"Post. Hig. Med. Dosw (Online)"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib106","article-title":"BRAF mutation in Chinese biliary tract cancer patients","volume":"38","author":"Li","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib107","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/modpathol.2013.206","article-title":"BRAF V600E-specific immunohistochemistry reveals low mutation rates in biliary tract cancer and restriction to intrahepatic cholangiocarcinoma","volume":"27","author":"Goeppert","year":"2014","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib108","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41571-021-00521-0","article-title":"The implications of IDH mutations for cancer development and therapy","volume":"18","author":"Pirozzi","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib109","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41408-021-00497-1","article-title":"Acute myeloid leukemia with IDH1 and IDH2 mutations: 2021 treatment algorithm","volume":"11","author":"Issa","year":"2021","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12032-018-1229-x","article-title":"Isocitrate dehydrogenase gene mutations and 2-hydroxyglutarate accumulation in esophageal squamous cell carcinoma.","volume":"36","author":"Miyake","year":"2018","journal-title":"Med. Oncol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib111","doi-asserted-by":"crossref","first-page":"15820","DOI":"10.1038\/s41598-020-72810-0","article-title":"Intrahepatic cholangiocarcinomas with IDH1\/2 mutation-associated hypermethylation at selective genes and their clinicopathological features","volume":"10","author":"Lee","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib112","doi-asserted-by":"crossref","first-page":"18775","DOI":"10.1038\/s41598-022-22543-z","article-title":"Molecular profile and its clinical impact of IDH1 mutated versus IDH1 wild type intrahepatic cholangiocarcinoma","volume":"12","author":"Rimini","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib113","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1126\/science.1236062","article-title":"An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells","volume":"340","author":"Rohle","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib114","first-page":"1653","article-title":"Deficient MGMT and proficient hMLH1 expression renders gallbladder carcinoma cells sensitive to alkylating agents through G2-M cell cycle arrest","volume":"26","author":"Sato","year":"2005","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib115","doi-asserted-by":"crossref","first-page":"9033","DOI":"10.1038\/sj.onc.1206095","article-title":"Gene silencing in phenomena related to DNA repair","volume":"21","author":"Mukai","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib116","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature07385","article-title":"Comprehensive genomic characterization defines human glioblastoma genes and core pathways","volume":"455","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib117","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/neuonc\/nox160","article-title":"Molecular differences in IDH wildtype glioblastoma according to MGMT promoter methylation.","volume":"20","author":"Kessler","year":"2018","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib118","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1080\/1120009X.2017.1312752","article-title":"MGMT gene variants, temozolomide myelotoxicity and glioma risk. A concise literature survey including an illustrative case","volume":"29","author":"Altinoz","year":"2017","journal-title":"J. Chemother."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib119","first-page":"4021","article-title":"The effect of o6-methylguanine-DNA methyltransferase (MGMT) and mismatch repair gene (hMLH1) status on the sensitivity to alkylating agent 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3- nitrosourea(ACNU) in gallbladder carcinoma cells","volume":"25","author":"Sato","year":"2005","journal-title":"Anticancer Res."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib120","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1245\/ASO.2005.07.020","article-title":"Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers","volume":"12","author":"Koga","year":"2005","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib121","first-page":"837","article-title":"Anticancer properties of capsaicin against human cancer","volume":"36","author":"Clark","year":"2016","journal-title":"Anticancer Res."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib122","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/01.MP.0000085760.74313.DD","article-title":"The p16 (CDKN2a\/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases","volume":"16","author":"Ai","year":"2003","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib123","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1158\/1078-0432.CCR-1137-3","article-title":"Alterations of p16 and prognosis in biliary tract cancers from a population- based study in China","volume":"10","author":"Ueki","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib124","doi-asserted-by":"crossref","first-page":"6396","DOI":"10.3748\/wjg.v13.i47.6396","article-title":"Two distinct pathways of p16 gene inactivation in gallbladder cancer","volume":"13","author":"Tadokoro","year":"2007","journal-title":"World J. Gastroenterol. WJG"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib125","article-title":"Molecular pathogenesis of gallbladder cancer: an update","volume":"816\u2013818","author":"Mishra","year":"2019","journal-title":"Mutat. Res. Fundam. Mol. Mech. Mutagen."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib126","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41392-021-00780-4","article-title":"KRAS mutation: from undruggable to druggable in cancer","volume":"6","author":"Huang","year":"2021","journal-title":"Signal. Transduct. Target Ther."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib127","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1038\/s41467-021-22125-z","article-title":"The origins and genetic interactions of KRAS mutations are allele- and tissue-specific","volume":"12","author":"Cook","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib128","unstructured":"K. Fan, J. Wang, ERBB2 S310F Mutation Independently activates PI3K \/ AKT And MAPK Pathways through Homo- Dimerization to Contribute Gallbladder Carcinoma Growth, (n.d.) 1\u201316."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib129","doi-asserted-by":"crossref","first-page":"114371","DOI":"10.18632\/oncotarget.22825","article-title":"Genomic alterations of ERBB receptors in cancer: clinical implications","volume":"8","author":"Mishra","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib130","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-016-0370-7","article-title":"The E545K mutation of PIK3CA promotes gallbladder carcinoma progression through enhanced binding to EGFR","volume":"35","author":"Zhao","year":"2016","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib131","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/onco.13545","article-title":"Acquired MET D1228N mutations mediate crizotinib resistance in lung adenocarcinoma with ROS1 fusion: a case report","volume":"26","author":"Wang","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib132","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1038\/sj.onc.1203628","article-title":"Tumorigenesis mediated by MET mutant M1268T is inhibited by dominant-negative Src","volume":"19","author":"Nakaigawa","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib133","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1158\/1535-7163.MCT-10-0799","article-title":"BRAFV600E: implications for carcinogenesis and molecular therapy","volume":"10","author":"Cantwell-Dorris","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib134","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.1038\/s41388-020-01414-9","article-title":"BRAFV600E drives dedifferentiation in small intestinal and colonic organoids and cooperates with mutant p53 and Apc loss in transformation","volume":"39","author":"Reischmann","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib135","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41698-022-00304-5","article-title":"Secondary IDH1 resistance mutations and oncogenic IDH2 mutations cause acquired resistance to ivosidenib in cholangiocarcinoma","volume":"6","author":"Cleary","year":"2022","journal-title":"NPJ Precis. Oncol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.aaq1427","article-title":"IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response","volume":"11","author":"N\u00fa\u00f1ez","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib137","doi-asserted-by":"crossref","first-page":"6485","DOI":"10.1007\/s13277-015-3339-9","article-title":"Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast","volume":"36","author":"Asiaf","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib138","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mrfmmm.2004.02.011","article-title":"Hypermethylation of the DNA repair gene MGMT: Association with TP53 G:C to A:T transitions in a series of 469 nervous system tumors","volume":"554","author":"Bello","year":"2004","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib139","first-page":"4397","article-title":"Transcriptional regulation of the p16 tumor suppressor gene","volume":"35","author":"Kotake","year":"2015","journal-title":"Anticancer Res."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib140","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1182\/blood-2006-05-024661","article-title":"Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implications","volume":"109","author":"Gonzalez-Paz","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib141","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41392-020-00412-3","article-title":"Whole-exome mutational landscape of neuroendocrine carcinomas of the gallbladder","volume":"6","author":"Liu","year":"2021","journal-title":"Signal. Transduct. Target Ther."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib142","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1742-4658.2008.06809.x","article-title":"Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced chemokine release in both TRAIL-resistant and TRAIL-sensitive cells via nuclear factor kappa B","volume":"276","author":"Tang","year":"2009","journal-title":"FEBS J."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib143","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/j.1440-1681.2009.05258.x","article-title":"Emerging role of tumour necrosis factor-related apoptosis- inducing ligand (TRAIL) as a key regulator of inflammatory responses","volume":"36","author":"Collison","year":"2009","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib144","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jconrel.2020.07.013","article-title":"TRAIL therapy and prospective developments for cancer treatment","volume":"326","author":"Thapa","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmolb.2021.628332","article-title":"The TRAIL in the treatment of human cancer: an update on clinical trials","volume":"8","author":"Snajdauf","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib146","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrc.2017.28","article-title":"Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy","volume":"17","author":"von Karstedt","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib147","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41418-022-01059-z","article-title":"Harnessing TRAIL-induced cell death for cancer therapy: a long walk with thrilling discoveries","volume":"30","author":"Montinaro","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib148","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/j.0022-202X.2005.23900.x","article-title":"Efficient TRAIL- R1\/DR4-mediated apoptosis in melanoma cells by tumor necrosis factor-related apoptosis- inducing ligand (TRAIL)","volume":"125","author":"Kurbanov","year":"2005","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib149","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41389-021-00322-1","article-title":"Precision modeling of gall bladder cancer patients in mice based on orthotopic implantation of organoid-derived tumor buds","volume":"10","author":"Kato","year":"2021","journal-title":"Oncogenesis"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib150","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/nrc2465","article-title":"The TRAIL apoptotic pathway in cancer onset, progression and therapy","volume":"8","author":"Johnstone","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib151","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3390\/cancers3010603","article-title":"Advances in viral vector-based TRAIL gene therapy for cancer","volume":"3","author":"Norian","year":"2011","journal-title":"Cancers"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib152","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.575597","article-title":"Localized interleukin-12 for cancer immunotherapy","volume":"11","author":"Nguyen","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib153","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41568-021-00363-z","article-title":"Interleukins in cancer: from biology to therapy","volume":"21","author":"Briukhovetska","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib154","first-page":"1393","article-title":"Extracellular expression of cytosine deaminase results in increased 5-FU production for enhanced enzyme\/prodrug therapy","volume":"24","author":"Rehemtulla","year":"2004","journal-title":"Anticancer Res."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib155","first-page":"BR13","article-title":"Antitumor efficiency of the cytosine deaminase\/5-fluorocytosine suicide gene therapy system on malignant gliomas: an in vivo study","volume":"15","author":"Lv","year":"2009","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib156","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41417-021-00331-7","article-title":"Vector engineering, strategies and targets in cancer gene therapy","volume":"29","author":"Singh","year":"2022","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib157","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1007\/s10529-008-9787-1","article-title":"Implication of functional activity for determining therapeutic efficacy of suicide genes in vitro","volume":"30","author":"Gopinath","year":"2008","journal-title":"Biotechnol. Lett."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib158","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12123586","article-title":"Immunomodulatory Effects of IL-2 and IL-15; Implications for Cancer Immunotherapy","volume":"12","author":"Yang","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib159","doi-asserted-by":"crossref","first-page":"9056173","DOI":"10.1155\/2018\/9056173","article-title":"Prospects of IL-2 in cancer immunotherapy","volume":"2018","author":"Choudhry","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib160","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1101\/gad.314617.118","article-title":"Roles of the immune system in cancer: from tumor initiation to metastatic progression","volume":"32","author":"Gonzalez","year":"2018","journal-title":"Genes Dev."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib161","first-page":"1","article-title":"Immunotherapy how immunotherapy is used to treat","author":"McDowell","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib162","doi-asserted-by":"crossref","first-page":"614","DOI":"10.14423\/SMJ.0000000000001295","article-title":"Immune checkpoint inhibitor-related pulmonary toxicity: a comprehensive review, part II","volume":"114","author":"Bukamur","year":"2021","journal-title":"South Med. J."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib163","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12030738","article-title":"Review of indications of FDA-approved immune checkpoint inhibitors per NCCN GUidelines with the Level of Evidence","volume":"12","author":"Vaddepally","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.mrfmmm.2024.111896_bib164","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.clinthera.2015.02.018","article-title":"The next immune-checkpoint inhibitors: PD-1\/PD-L1 blockade in melanoma","volume":"37","author":"Mahoney","year":"2015","journal-title":"Clin. Ther."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib165","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41571-019-0218-0","article-title":"Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance","volume":"16","author":"Martins","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib166","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1200\/JCO.21.01440","article-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO Guideline Update","volume":"39","author":"Schneider","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib167","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu Rev. Immunol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib168","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20204981","article-title":"Role of phytochemicals in cancer prevention","volume":"20","author":"Ranjan","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib169","first-page":"1861","article-title":"Antiproliferative and apoptosis- inducing activity of curcumin against human gallbladder adenocarcinoma cells","volume":"33","author":"Ono","year":"2013","journal-title":"Anticancer Res."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib170","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/nyas.13466","article-title":"Resveratrol and cancer treatment: updates","volume":"1403","author":"Jiang","year":"2017","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib171","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.860209","article-title":"Application of quercetin in the treatment of gastrointestinal cancers","volume":"13","author":"Mirazimi","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib172","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.2174\/0929867322666150812145435","article-title":"Quercetin in cancer treatment, alone or in combination with conventional therapeutics?","volume":"22","author":"Brito","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib173","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.2174\/187152012803529691","article-title":"Dual roles of sulforaphane in cancer treatment","volume":"12","author":"Xu","year":"2012","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.mrfmmm.2024.111896_bib174","doi-asserted-by":"crossref","first-page":"35412","DOI":"10.18632\/oncotarget.16015","article-title":"Sulforaphane for the chemoprevention of bladder cancer: molecular mechanism targeted approach","volume":"8","author":"Leone","year":"2017","journal-title":"Oncotarget"}],"container-title":["Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027510724000460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027510724000460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T13:30:45Z","timestamp":1764336645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0027510724000460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":174,"alternative-id":["S0027510724000460"],"URL":"https:\/\/doi.org\/10.1016\/j.mrfmmm.2024.111896","relation":{},"ISSN":["1386-1964"],"issn-type":[{"value":"1386-1964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genomic and molecular landscape of gallbladder cancer elucidating pathogenic mechanisms novel therapeutic targets and clinical implications","name":"articletitle","label":"Article Title"},{"value":"Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mrfmmm.2024.111896","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111896"}}